Bronchiectasis is conventionally defined as irreversible dilatation of the bronchial tree.
Bronchiectasis unrelated to cystic fibrosis is an increasingly appreciated cause of chronic …

Bronchiectasis refers to abnormal dilatation of the bronchi. Airway dilatation can lead to
failure of mucus clearance and increased risk of infection. Pathophysiological mechanisms …

Bronchiectasis in adults is a chronic disorder associated with poor quality of life and frequent
exacerbations in many patients. There have been no previous international guidelines. The …

Formerly regarded as a rare disease, bronchiectasis is now increasingly recognised and a
renewed interest in the condition is stimulating drug development and clinical research …

Abstract In 2008, the Spanish Society of Pulmonology (SEPAR) published the first
guidelines in the world on the diagnosis and treatment of bronchiectasis. Almost 10 years …

Bronchiectasis is a disease of renewed interest in light of an increase in prevalence and
increasing burden on international healthcare systems. There are no licensed therapies …

The management of bronchial secretions is one of the main problems encountered in a wide
spectrum of medical conditions ranging from respiratory disorders, neuromuscular disorders …

Keeping airways clear of mucus by airway clearance techniques seems essential in
bronchiectasis treatment, although no placebo-controlled trials or any studies lasting longer …

Bronchiectasis is described classically as a chronic pulmonary disorder characterized by a
persistent productive cough and irreversible dilatation of one or more bronchi. However, in …

The diagnostic label “bronchiectasis” describes the existence of localised and permanent
airway dilation, but when used to describe a disease it includes a heterogeneous group of …